- Home
- ZLAB vs IRTC Comparison
ZLAB vs IRTC Comparison
Compare ZLAB & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- IRTC
- Stock Information
- Founded
- ZLAB 2013
- IRTC 2006
- Country
- ZLAB China
- IRTC United States
- Employees
- ZLAB N/A
- IRTC N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- IRTC Medical/Dental Instruments
- Sector
- ZLAB Health Care
- IRTC Health Care
- Exchange
- ZLAB Nasdaq
- IRTC Nasdaq
- Market Cap
- ZLAB 4.3B
- IRTC 4.9B
- IPO Year
- ZLAB 2017
- IRTC 2016
- Fundamental
- Price
- ZLAB $34.96
- IRTC $158.50
- Analyst Decision
- ZLAB Buy
- IRTC Strong Buy
- Analyst Count
- ZLAB 5
- IRTC 10
- Target Price
- ZLAB $54.28
- IRTC $157.30
- AVG Volume (30 Days)
- ZLAB 860.8K
- IRTC 497.5K
- Earning Date
- ZLAB 08-07-2025
- IRTC 07-31-2025
- Dividend Yield
- ZLAB N/A
- IRTC N/A
- EPS Growth
- ZLAB N/A
- IRTC N/A
- EPS
- ZLAB N/A
- IRTC N/A
- Revenue
- ZLAB $427,799,000.00
- IRTC $657,227,000.00
- Revenue This Year
- ZLAB $45.16
- IRTC $19.91
- Revenue Next Year
- ZLAB $56.81
- IRTC $16.80
- P/E Ratio
- ZLAB N/A
- IRTC N/A
- Revenue Growth
- ZLAB 32.56
- IRTC 22.37
- 52 Week Low
- ZLAB $16.01
- IRTC $55.92
- 52 Week High
- ZLAB $44.34
- IRTC $168.32
- Technical
- Relative Strength Index (RSI)
- ZLAB 45.24
- IRTC 63.24
- Support Level
- ZLAB $33.17
- IRTC $155.00
- Resistance Level
- ZLAB $39.64
- IRTC $168.32
- Average True Range (ATR)
- ZLAB 1.19
- IRTC 5.19
- MACD
- ZLAB -0.31
- IRTC 2.58
- Stochastic Oscillator
- ZLAB 22.29
- IRTC 72.84
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About IRTC iRhythm Technologies Inc.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.